ProtoKinetix, Inc. (PKTX) financial statements (2022 and earlier)

Company profile

Business Address 412 MULBERRY STREET
MARIETTA, OH 45750
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments58193377136303371371
Cash and cash equivalents58193377136303371371
Receivables      8
Prepaid expense2611162700
Total current assets:84194378137365441379
Noncurrent Assets
Intangible assets, net (including goodwill)36327520818815310170
Intangible assets, net (excluding goodwill)36327520818815310170
Total noncurrent assets:36327520818815310170
TOTAL ASSETS:446469586325518542450
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:93272679274545
Accounts payable93      
Other undisclosed accounts payable and accrued liabilities 272679274545
Debt    118  
Other undisclosed current liabilities (9)     
Total current liabilities:931826791454545
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 27     
Total noncurrent liabilities: 27     
Total liabilities:934526791454545
Stockholders' equity
Stockholders' equity attributable to parent353424560246374497404
Common stock2211111
Additional paid in capital45,89343,61536,10731,59530,50629,11627,499
Accumulated deficit(45,541)(43,193)(35,548)(31,350)(30,134)(28,620)(27,096)
Other undisclosed stockholders' equity 0     
Total stockholders' equity:353424560246374497404
TOTAL LIABILITIES AND EQUITY:446469586325518542450

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Gross profit:      (125)
Operating expenses(2,329)(7,644)(4,198)(1,216)(1,514)(1,525)(1,262)
Operating loss:(2,329)(7,644)(4,198)(1,216)(1,514)(1,525)(1,387)
Interest and debt expense   (0)(2)(0)7
Net loss:(2,329)(7,644)(4,198)(1,217)(1,515)(1,525)(1,380)
Other undisclosed net income attributable to parent   020125
Net loss available to common stockholders, diluted:(2,329)(7,644)(4,198)(1,216)(1,514)(1,525)(1,255)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(2,329)(7,644)(4,198)(1,217)(1,515)(1,525)(1,380)
Comprehensive loss, net of tax, attributable to parent:(2,329)(7,644)(4,198)(1,217)(1,515)(1,525)(1,380)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: